Tafoxiparin, a novel drug candidate for cervical ripening and labor augmentation: results from 2 randomized, placebo-controlled studies-Reference-Cited by-同舟云学术

Tafoxiparin, a novel drug candidate for cervical ripening and labor augmentation: results from 2 randomized, placebo-controlled studies

Published:2023-05 Issue: Volume: Page:
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Ekman-Ordeberg Gunvor^ORCID,Hellgren-Wångdahl Margareta^ORCID,Jeppson Annika,Rahkonen Leena,Blomberg Marie^ORCID,Pettersson Karin,Bejlum Carina,Engberg Malin,Ludvigsen Mette,Uotila Jukka,Tihtonen Kati^ORCID,Hallberg Gunilla,Jonsson Maria

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference31 articles.

1. Induction of labor at 41 weeks of pregnancy among primiparas with an unfavorable bishop score;Marroquin;Arch Gynecol Obstet,2013

2. Factors associated with emergency cesarean delivery during induction of labor in nulliparous women aged 35 years or older at term;Nakano;J Obstet Gynaecol Res,2018

3. Failed labor induction: toward an objective diagnosis;Rouse;Obstet Gynecol,2011

4. “Active labor” duration and dilation rates among low-risk, nulliparous women with spontaneous labor onset: a systematic review;Neal;J Midwifery Womens Health,2010

5. Diverse definitions of prolonged labour and its consequences with sometimes subsequent inappropriate treatment;Nystedt;BMC Pregnancy Childbirth,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parturition at term: induction, second and third stages of labor, and optimal management of life-threatening complications—hemorrhage, infection, and uterine rupture;American Journal of Obstetrics and Gynecology;2024-03